×
About 34,623 results

ALLMedicine™ Renal Failure Center

Research & Reviews  10,593 results

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04634552

Aug 12th, 2022 - Multiple myeloma is a malignant plasma cell disorder characterized by osteolytic lesions, increased susceptibility to infections, hypercalcemia, and renal failure. Talquetamab is a humanized immunoglobulin G4 proline, alanine, alanine (IgG4PAA) bi...

18F-PSMA-1007 PET/CT Imaging in Patients With Biochemically Recurrent or High-risk Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT04733768

Aug 12th, 2022 - A single centre prospective cohort phase II study of 18F-PSMA-1007 PET/CT imaging in specific patient populations: Adult patients (≥ 18 years old) with a history of radical prostatectomy for treatment of prostate cancer, and a serum prostate speci...

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04933539

Aug 12th, 2022 - Background: Smoldering multiple myeloma (SMM) is a precursor condition to MM defined by the clinical parameters of M-protein >=3.0 g/dL or bone marrow plasma cells >=10%, and absence of end organ disease. Patients with high-risk SMM have a risk of...

A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04108195

Aug 12th, 2022 - Multiple myeloma is a malignant plasma cell disorder characterized by osteolytic lesions, increased susceptibility to infections, hypercalcemia, and renal failure. Overall rationale of study is that daratumumab in combination with talquetamab or t...

Renal and Urological Disorders Associated With Inflammatory Bowel Disease.
https://doi.org/10.1093/ibd/izac140
Inflammatory Bowel Diseases; Kumar S, Pollok R et. al.

Aug 10th, 2022 - Renal and urinary tract complications related to inflammatory bowel disease (IBD) have been relatively understudied in the literature compared with other extraintestinal manifestations. Presentation of these renal manifestations can be subtle, and...

see more →

Guidelines  16 results

Management of rhabdomyolysis: A practice management guideline from the Eastern Associat...
https://doi.org/10.1016/j.amjsurg.2021.11.022
American Journal of Surgery; Sawhney JS, Kasotakis G et. al.

Nov 28th, 2021 - The treatment of rhabdomyolysis remains controversial. Although there is no question that any associated compartment syndrome needs to be identified and released, debate persists regarding the benefit of further therapy including aggressive intrav...

ACR Appropriateness Criteria® Renal Failure.
https://doi.org/10.1016/j.jacr.2021.02.019
Journal of the American College of Radiology : JACR; , Wong-You-Cheong JJ et. al.

May 8th, 2021 - Renal failure can be divided into acute kidney injury and chronic kidney disease. Both are common and result in increased patient morbidity and mortality. The etiology is multifactorial and differentiation of acute kidney injury from chronic kidne...

A living WHO guideline on drugs for covid-19
https://doi.org/10.1136/bmj.m3379
BMJ (Clinical Research Ed.); Agarwal A, Rochwerg B et. al.

Sep 6th, 2020 - This is the eleventh version (tenth update) of the living guideline, replacing earlier versions (available as data supplements). New recommendations will be published as updates to this guideline. What is the role of drugs in the treatment of pati...

Society for Vascular Surgery clinical practice guidelines of thoracic endovascular aort...
https://doi.org/10.1016/j.jvs.2020.05.076
Journal of Vascular Surgery; Upchurch GR, Escobar GA et. al.

Jul 7th, 2020 - Thoracic aortic diseases, including disease of the descending thoracic aorta (DTA), are significant causes of death in the United States. Open repair of the DTA is a physiologically impactful operation with relatively high rates of mortality, para...

ACR Appropriateness Criteria® Radiologic Management of Urinary Tract Obstruction.
https://doi.org/10.1016/j.jacr.2020.01.039
Journal of the American College of Radiology : JACR; , Scheidt MJ et. al.

May 7th, 2020 - Acute obstructive uropathy is a medical emergency, which often is accompanied by acute renal failure or sepsis. Treatment options to resolve the acute obstructive process include conservative medical management, retrograde ureteral stenting, or pl...

see more →

Drugs  540 results see all →

Clinicaltrials.gov  1,530 results

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04634552

Aug 12th, 2022 - Multiple myeloma is a malignant plasma cell disorder characterized by osteolytic lesions, increased susceptibility to infections, hypercalcemia, and renal failure. Talquetamab is a humanized immunoglobulin G4 proline, alanine, alanine (IgG4PAA) bi...

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04933539

Aug 12th, 2022 - Background: Smoldering multiple myeloma (SMM) is a precursor condition to MM defined by the clinical parameters of M-protein >=3.0 g/dL or bone marrow plasma cells >=10%, and absence of end organ disease. Patients with high-risk SMM have a risk of...

18F-PSMA-1007 PET/CT Imaging in Patients With Biochemically Recurrent or High-risk Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT04733768

Aug 12th, 2022 - A single centre prospective cohort phase II study of 18F-PSMA-1007 PET/CT imaging in specific patient populations: Adult patients (≥ 18 years old) with a history of radical prostatectomy for treatment of prostate cancer, and a serum prostate speci...

A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04108195

Aug 12th, 2022 - Multiple myeloma is a malignant plasma cell disorder characterized by osteolytic lesions, increased susceptibility to infections, hypercalcemia, and renal failure. Overall rationale of study is that daratumumab in combination with talquetamab or t...

Evaluation of a Nurse-led Program for the Prevention of Complications of Long-term Corticosteroid Therapy
https://clinicaltrials.gov/ct2/show/NCT04909606

Aug 8th, 2022 - It is a PROBE (Prospective Randomized Open trial with a Blind Evaluation) study, in which the primary endpoint will be assessed at week-52 by an independent physician blinded to the participant's allocation group. The target population is adult pa...

see more →

News  1,167 results

Long COVID Doubles Risk of Some Serious Outcomes in Children, Teens
https://www.medscape.com/viewarticle/978736

Aug 5th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. CDC researchers report that children and teenagers with long COVID have about twice the risk of getting serious outcomes, compared to others witho...

No More 'Escape Hatch': Post Roe, New Worries About Meds Linked to Birth Defects
https://www.medscape.com/viewarticle/976370

Jun 29th, 2022 - As states ban or limit abortion in the wake of the demise of Roe v. Wade, physicians are turning their attention to widely used drugs that can cause birth defects. At issue: Should these drugs still be prescribed to women of childbearing age if th...

High Maternal, Fetal Morbidity Rates in SLE Pregnancies
https://www.medscape.com/viewarticle/974934

Jun 2nd, 2022 - COPENHAGEN — Pregnant women with systemic lupus erythematosus (SLE) are at significantly higher risk of requiring transfusion, developing a cerebrovascular disorder, or developing acute renal failure than pregnant women without SLE, a review of da...

Retiform Purpura on the Legs
https://www.mdedge.com/dermatology/article/254484/dermatopathology/retiform-purpura-legs
Mark C. Marchitto, MD, Liesl Grenier, MD et. al.

May 10th, 2022 - The Diagnosis: Calciphylaxis Histopathology revealed epidermal and dermal necrosis, a perivascular neutrophilic infiltrate, and scattered microcalcifications within small- and medium-sized subcutaneous vessels, consistent with a diagnosis of calci.

Dr. Larocca on Recent Advancements in R/R Multiple Myeloma
https://www.onclive.com/view/dr-larocca-on-recent-advancements-in-r-r-multiple-myeloma

Apr 20th, 2022 - Alessandra Larocca, MD, PhD, hematologist, Division of Hematology, University of Torino, Azienda Ospedaliero‐Universitaria Città della Salute e della Scienza di Torino, Italy, discusses recent advancements in relapsed/refractory multiple myeloma. ...

see more →

Patient Education  3 results see all →